{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:06:46Z","timestamp":1789733206660,"version":"4.0.1"},"reference-count":265,"publisher":"Aging and Disease","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14336\/ad.2020.0222","type":"journal-article","created":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T15:27:27Z","timestamp":1596382047000},"page":"828","source":"Crossref","is-referenced-by-count":77,"title":["TGF-\u03b2 Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?"],"prefix":"10.14336","volume":"11","author":[{"given":"Mahesh","family":"Kandasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuswamy","family":"Anusuyadevi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera M","family":"Aigner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Unger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin M","family":"Kniewallner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M Bessa de","family":"Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altendorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Mrowetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bogdahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Aigner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2020.0222-1","doi-asserted-by":"crossref","unstructured":"Cerejeira J, Lagarto L, Mukaetova-Ladinska EB (2012). Behavioral and psychological symptoms of dementia. Front Neurol, 3:73.","DOI":"10.3389\/fneur.2012.00073"},{"key":"key-10.14336\/AD.2020.0222-2","doi-asserted-by":"crossref","unstructured":"O'Brien JT, Thomas A (2015). Vascular dementia. Lancet, 386:1698-1706.","DOI":"10.1016\/S0140-6736(15)00463-8"},{"key":"key-10.14336\/AD.2020.0222-3","unstructured":"Collaborators GBDD (2019). Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 18:88-106."},{"key":"key-10.14336\/AD.2020.0222-4","doi-asserted-by":"crossref","unstructured":"Rizzi L, Rosset I, Roriz-Cruz M (2014). Global epidemiology of dementia: Alzheimer's and vascular types. Biomed Res Int, 2014:908915.","DOI":"10.1155\/2014\/908915"},{"key":"key-10.14336\/AD.2020.0222-5","doi-asserted-by":"crossref","unstructured":"Podcasy JL, Epperson CN (2016). Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci, 18:437-446.","DOI":"10.31887\/DCNS.2016.18.4\/cepperson"},{"key":"key-10.14336\/AD.2020.0222-6","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2013). Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci, 5:17.","DOI":"10.3389\/fnagi.2013.00017"},{"key":"key-10.14336\/AD.2020.0222-7","doi-asserted-by":"crossref","unstructured":"Feigin VL, Norrving B, Mensah GA (2016). Primary prevention of cardiovascular disease through population-wide motivational strategies: insights from using smartphones in stroke prevention. BMJ Glob Health, 2:e000306.","DOI":"10.1136\/bmjgh-2017-000306"},{"key":"key-10.14336\/AD.2020.0222-8","doi-asserted-by":"crossref","unstructured":"Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF (1997). Classification, diagnosis and treatment of vascular dementia. Drugs Aging, 11:361-373.","DOI":"10.2165\/00002512-199711050-00004"},{"key":"key-10.14336\/AD.2020.0222-9","doi-asserted-by":"crossref","unstructured":"Venkat P, Chopp M, Chen J (2015). Models and mechanisms of vascular dementia. Exp Neurol, 272:97-108.","DOI":"10.1016\/j.expneurol.2015.05.006"},{"key":"key-10.14336\/AD.2020.0222-10","doi-asserted-by":"crossref","unstructured":"Guo X, Ostling S, Kern S, Johansson L, Skoog I (2018). Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years. Alzheimers Dement, 14:1253-1260.","DOI":"10.1016\/j.jalz.2018.05.009"},{"key":"key-10.14336\/AD.2020.0222-11","doi-asserted-by":"crossref","unstructured":"Pendlebury ST, Rothwell PM, Oxford Vascular S (2019). Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol, 18:248-258.","DOI":"10.1016\/S1474-4422(18)30442-3"},{"key":"key-10.14336\/AD.2020.0222-12","doi-asserted-by":"crossref","unstructured":"Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, et al. (1995). Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet, 346:934-939.","DOI":"10.1016\/S0140-6736(95)91557-5"},{"key":"key-10.14336\/AD.2020.0222-13","doi-asserted-by":"crossref","unstructured":"DiFrancesco JC, Novara F, Zuffardi O, Forlino A, Gioia R, Cossu F, et al. (2015). TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci, 36:323-330.","DOI":"10.1007\/s10072-014-1944-9"},{"key":"key-10.14336\/AD.2020.0222-14","doi-asserted-by":"crossref","unstructured":"Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383:707-710.","DOI":"10.1038\/383707a0"},{"key":"key-10.14336\/AD.2020.0222-15","doi-asserted-by":"crossref","unstructured":"Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, et al. (2007). C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet, 39:1068-1070.","DOI":"10.1038\/ng2082"},{"key":"key-10.14336\/AD.2020.0222-16","doi-asserted-by":"crossref","unstructured":"Kalaria RN, Erkinjuntti T (2006). Small vessel disease and subcortical vascular dementia. J Clin Neurol, 2:1-11.","DOI":"10.3988\/jcn.2006.2.1.1"},{"key":"key-10.14336\/AD.2020.0222-17","doi-asserted-by":"crossref","unstructured":"Kalaria RN (2018). The pathology and pathophysiology of vascular dementia. Neuropharmacology, 134:226-239.","DOI":"10.1016\/j.neuropharm.2017.12.030"},{"key":"key-10.14336\/AD.2020.0222-18","doi-asserted-by":"crossref","unstructured":"Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C (2009). Pathophysiology of vascular dementia. Immun Ageing, 6:13.","DOI":"10.1186\/1742-4933-6-13"},{"key":"key-10.14336\/AD.2020.0222-19","doi-asserted-by":"crossref","unstructured":"Battistin L, Cagnin A (2010). Vascular cognitive disorder. A biological and clinical overview. Neurochem Res, 35:1933-1938.","DOI":"10.1007\/s11064-010-0346-5"},{"key":"key-10.14336\/AD.2020.0222-20","doi-asserted-by":"crossref","unstructured":"Kanekar S, Poot JD (2014). Neuroimaging of vascular dementia. Radiol Clin North Am, 52:383-401.","DOI":"10.1016\/j.rcl.2013.11.004"},{"key":"key-10.14336\/AD.2020.0222-21","doi-asserted-by":"crossref","unstructured":"Lambert C, Zeestraten E, Williams O, Benjamin P, Lawrence AJ, Morris RG, et al. (2018). Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI. Neuroimage Clin, 19:925-938.","DOI":"10.1016\/j.nicl.2018.06.023"},{"key":"key-10.14336\/AD.2020.0222-22","doi-asserted-by":"crossref","unstructured":"Malojcic B, Giannakopoulos P, Sorond FA, Azevedo E, Diomedi M, Oblak JP, et al. (2017). Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease. BMC Med, 15:27.","DOI":"10.1186\/s12916-017-0799-3"},{"key":"key-10.14336\/AD.2020.0222-23","doi-asserted-by":"crossref","unstructured":"van Straaten EC, Scheltens P, Barkhof F (2004). MRI and CT in the diagnosis of vascular dementia. J Neurol Sci, 226:9-12.","DOI":"10.1016\/j.jns.2004.09.003"},{"key":"key-10.14336\/AD.2020.0222-24","doi-asserted-by":"crossref","unstructured":"Moulin S, Labreuche J, Bombois S, Rossi C, Boulouis G, Henon H, et al. (2016). Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol, 15:820-829.","DOI":"10.1016\/S1474-4422(16)00130-7"},{"key":"key-10.14336\/AD.2020.0222-25","doi-asserted-by":"crossref","unstructured":"Xiong XY, Liu L, Wang FX, Yang YR, Hao JW, Wang PF, et al. (2016). Toll-Like Receptor 4\/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage. Circulation, 134:1025-1038.","DOI":"10.1161\/CIRCULATIONAHA.116.021881"},{"key":"key-10.14336\/AD.2020.0222-26","doi-asserted-by":"crossref","unstructured":"You S, Wang X, Lindley RI, Robinson T, Anderson CS, Cao Y, et al. (2017). Early Cognitive Impairment after Intracerebral Hemorrhage in the INTERACT1 Study. Cerebrovasc Dis, 44:320-324.","DOI":"10.1159\/000481443"},{"key":"key-10.14336\/AD.2020.0222-27","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018). Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol, 14:133-150.","DOI":"10.1038\/nrneurol.2017.188"},{"key":"key-10.14336\/AD.2020.0222-28","doi-asserted-by":"crossref","unstructured":"Ueno M, Chiba Y, Matsumoto K, Murakami R, Fujihara R, Kawauchi M, et al. (2016). Blood-brain barrier damage in vascular dementia. Neuropathology, 36:115-124.","DOI":"10.1111\/neup.12262"},{"key":"key-10.14336\/AD.2020.0222-29","doi-asserted-by":"crossref","unstructured":"Wallin A, Blennow K, Fredman P, Gottfries CG, Karlsson I, Svennerholm L (1990). Blood brain barrier function in vascular dementia. Acta Neurol Scand, 81:318-322.","DOI":"10.1111\/j.1600-0404.1990.tb01562.x"},{"key":"key-10.14336\/AD.2020.0222-30","doi-asserted-by":"crossref","unstructured":"Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, et al. (2017). Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report. BMC Neurol, 17:102.","DOI":"10.1186\/s12883-017-0877-3"},{"key":"key-10.14336\/AD.2020.0222-31","doi-asserted-by":"crossref","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015). Establishment and Dysfunction of the Blood-Brain Barrier. Cell, 163:1064-1078.","DOI":"10.1016\/j.cell.2015.10.067"},{"key":"key-10.14336\/AD.2020.0222-32","doi-asserted-by":"crossref","unstructured":"Demuth HU, Dijkhuizen RM, Farr TD, Gelderblom M, Horsburgh K, Iadecola C, et al. (2017). Recent progress in translational research on neurovascular and neurodegenerative disorders. Restor Neurol Neurosci, 35:87-103.","DOI":"10.3233\/RNN-160690"},{"key":"key-10.14336\/AD.2020.0222-33","doi-asserted-by":"crossref","unstructured":"Rivera FJ, Silva ME, Aigner L (2017). Editorial: The Vascular Niche in Tissue Repair: A Therapeutic Target for Regeneration. Front Cell Dev Biol, 5:88.","DOI":"10.3389\/fcell.2017.00088"},{"key":"key-10.14336\/AD.2020.0222-34","doi-asserted-by":"crossref","unstructured":"Kim Y, Lee C (2006). The gene encoding transforming growth factor beta 1 confers risk of ischemic stroke and vascular dementia. Stroke, 37:2843-2845.","DOI":"10.1161\/01.STR.0000244782.76917.87"},{"key":"key-10.14336\/AD.2020.0222-35","doi-asserted-by":"crossref","unstructured":"Aigner L, Bogdahn U (2008). TGF-beta in neural stem cells and in tumors of the central nervous system. Cell Tissue Res, 331:225-241.","DOI":"10.1007\/s00441-007-0466-7"},{"key":"key-10.14336\/AD.2020.0222-36","doi-asserted-by":"crossref","unstructured":"Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, et al. (2011). TGF-beta1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther, 17:237-249.","DOI":"10.1111\/j.1755-5949.2009.00115.x"},{"key":"key-10.14336\/AD.2020.0222-37","doi-asserted-by":"crossref","unstructured":"Henrich-Noack P, Prehn JH, Krieglstein J (1996). TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke, 27:1609-1614; discussion 1615.","DOI":"10.1161\/01.STR.27.9.1609"},{"key":"key-10.14336\/AD.2020.0222-38","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Lehner B, Kraus S, Sander PR, Marschallinger J, Rivera FJ, et al. (2014). TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med, 18:1444-1459.","DOI":"10.1111\/jcmm.12298"},{"key":"key-10.14336\/AD.2020.0222-39","doi-asserted-by":"crossref","unstructured":"Gomez-Duran A, Mulero-Navarro S, Chang X, Fernandez-Salguero PM (2006). LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase. J Cell Biochem, 97:380-392.","DOI":"10.1002\/jcb.20637"},{"key":"key-10.14336\/AD.2020.0222-40","doi-asserted-by":"crossref","unstructured":"Annes JP, Munger JS, Rifkin DB (2003). Making sense of latent TGFbeta activation. J Cell Sci, 116:217-224.","DOI":"10.1242\/jcs.00229"},{"key":"key-10.14336\/AD.2020.0222-41","doi-asserted-by":"crossref","unstructured":"Liu RM, Desai LP (2015). Reciprocal regulation of TGF-beta and reactive oxygen species: A perverse cycle for fibrosis. Redox Biol, 6:565-577.","DOI":"10.1016\/j.redox.2015.09.009"},{"key":"key-10.14336\/AD.2020.0222-42","doi-asserted-by":"crossref","unstructured":"Lyons RM, Keski-Oja J, Moses HL (1988). Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol, 106:1659-1665.","DOI":"10.1083\/jcb.106.5.1659"},{"key":"key-10.14336\/AD.2020.0222-43","doi-asserted-by":"crossref","unstructured":"Nocera M, Chu TM (1995). Characterization of latent transforming growth factor-beta from human seminal plasma. Am J Reprod Immunol, 33:282-291.","DOI":"10.1111\/j.1600-0897.1995.tb00897.x"},{"key":"key-10.14336\/AD.2020.0222-44","doi-asserted-by":"crossref","unstructured":"Schmierer B, Hill CS (2007). TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol, 8:970-982.","DOI":"10.1038\/nrm2297"},{"key":"key-10.14336\/AD.2020.0222-45","doi-asserted-by":"crossref","unstructured":"Luo K (2017). Signaling Cross Talk between TGF-beta\/Smad and Other Signaling Pathways. Cold Spring Harb Perspect Biol, 9.","DOI":"10.1101\/cshperspect.a022137"},{"key":"key-10.14336\/AD.2020.0222-46","doi-asserted-by":"crossref","unstructured":"Krieglstein K, Strelau J, Schober A, Sullivan A, Unsicker K (2002). TGF-beta and the regulation of neuron survival and death. J Physiol Paris, 96:25-30.","DOI":"10.1016\/S0928-4257(01)00077-8"},{"key":"key-10.14336\/AD.2020.0222-47","doi-asserted-by":"crossref","unstructured":"Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P (2009). Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol, 219:449-458.","DOI":"10.1002\/jcp.21706"},{"key":"key-10.14336\/AD.2020.0222-48","doi-asserted-by":"crossref","unstructured":"Patel RK, Prasad N, Kuwar R, Haldar D, Abdul-Muneer PM (2017). Transforming growth factor-beta 1 signaling regulates neuroinflammation and apoptosis in mild traumatic brain injury. Brain Behav Immun, 64:244-258.","DOI":"10.1016\/j.bbi.2017.04.012"},{"key":"key-10.14336\/AD.2020.0222-49","doi-asserted-by":"crossref","unstructured":"Ronaldson PT, Demarco KM, Sanchez-Covarrubias L, Solinsky CM, Davis TP (2009). Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab, 29:1084-1098.","DOI":"10.1038\/jcbfm.2009.32"},{"key":"key-10.14336\/AD.2020.0222-50","doi-asserted-by":"crossref","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009). Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol, 9:447-453.","DOI":"10.1016\/j.coph.2009.04.008"},{"key":"key-10.14336\/AD.2020.0222-51","doi-asserted-by":"crossref","unstructured":"Diniz LP, Tortelli V, Matias I, Morgado J, Bergamo Araujo AP, Melo HM, et al. (2017). Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Abeta Oligomers in Alzheimer's Disease Model. J Neurosci, 37:6797-6809.","DOI":"10.1523\/JNEUROSCI.3351-16.2017"},{"key":"key-10.14336\/AD.2020.0222-52","doi-asserted-by":"crossref","unstructured":"Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, et al. (2001). Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab, 21:157-162.","DOI":"10.1097\/00004647-200102000-00007"},{"key":"key-10.14336\/AD.2020.0222-53","doi-asserted-by":"crossref","unstructured":"Merrilees MJ, Sodek J (1992). Synthesis of TGF-beta 1 by vascular endothelial cells is correlated with cell spreading. J Vasc Res, 29:376-384.","DOI":"10.1159\/000158954"},{"key":"key-10.14336\/AD.2020.0222-54","doi-asserted-by":"crossref","unstructured":"Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS (2010). TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation, 7:62.","DOI":"10.1186\/1742-2094-7-62"},{"key":"key-10.14336\/AD.2020.0222-55","doi-asserted-by":"crossref","unstructured":"Gao Z, Zhu Q, Zhang Y, Zhao Y, Cai L, Shields CB, et al. (2013). Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury. Mol Neurobiol, 48:690-701.","DOI":"10.1007\/s12035-013-8460-4"},{"key":"key-10.14336\/AD.2020.0222-56","doi-asserted-by":"crossref","unstructured":"Johns LD, Babcock G, Green D, Freedman M, Sriram S, Ransohoff RM (1992). Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res, 585:229-236.","DOI":"10.1016\/0006-8993(92)91211-V"},{"key":"key-10.14336\/AD.2020.0222-57","doi-asserted-by":"crossref","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016). TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol, 12:325-338.","DOI":"10.1038\/nrneph.2016.48"},{"key":"key-10.14336\/AD.2020.0222-58","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L (2011). Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. Neurol Res Int, 2011:124256.","DOI":"10.1155\/2011\/124256"},{"key":"key-10.14336\/AD.2020.0222-59","doi-asserted-by":"crossref","unstructured":"Muller K, Courtois G, Ursini MV, Schwaninger M (2017). New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases. Stroke, 48:520-527.","DOI":"10.1161\/STROKEAHA.116.012888"},{"key":"key-10.14336\/AD.2020.0222-60","doi-asserted-by":"crossref","unstructured":"Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, et al. (2002). Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging, 23:237-243.","DOI":"10.1016\/S0197-4580(01)00285-8"},{"key":"key-10.14336\/AD.2020.0222-61","doi-asserted-by":"crossref","unstructured":"Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, et al. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest, 116:3060-3069.","DOI":"10.1172\/JCI27341"},{"key":"key-10.14336\/AD.2020.0222-62","doi-asserted-by":"crossref","unstructured":"Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000). Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol, 156:139-150.","DOI":"10.1016\/S0002-9440(10)64713-X"},{"key":"key-10.14336\/AD.2020.0222-63","doi-asserted-by":"crossref","unstructured":"Peila R, Yucesoy B, White LR, Johnson V, Kashon ML, Wu K, et al. (2007). A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS. Neurobiol Aging, 28:1367-1373.","DOI":"10.1016\/j.neurobiolaging.2006.06.004"},{"key":"key-10.14336\/AD.2020.0222-64","doi-asserted-by":"crossref","unstructured":"Sun JH, Tan L, Wang HF, Tan MS, Tan L, Li JQ, et al. (2015). Genetics of Vascular Dementia: Systematic Review and Meta-Analysis. J Alzheimers Dis, 46:611-629.","DOI":"10.3233\/JAD-143102"},{"key":"key-10.14336\/AD.2020.0222-65","doi-asserted-by":"crossref","unstructured":"Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L (2006). Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci, 23:2648-2656.","DOI":"10.1111\/j.1460-9568.2006.04780.x"},{"key":"key-10.14336\/AD.2020.0222-66","doi-asserted-by":"crossref","unstructured":"Grammas P, Ovase R (2002). Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. Am J Pathol, 160:1583-1587.","DOI":"10.1016\/S0002-9440(10)61105-4"},{"key":"key-10.14336\/AD.2020.0222-67","doi-asserted-by":"crossref","unstructured":"Malaguarnera L, Motta M, Di Rosa M, Anzaldi M, Malaguarnera M (2006). Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia. Neuropathology, 26:307-312.","DOI":"10.1111\/j.1440-1789.2006.00701.x"},{"key":"key-10.14336\/AD.2020.0222-68","doi-asserted-by":"crossref","unstructured":"Trigiani LJ, Hamel E (2017). An endothelial link between the benefits of physical exercise in dementia. J Cereb Blood Flow Metab, 37:2649-2664.","DOI":"10.1177\/0271678X17714655"},{"key":"key-10.14336\/AD.2020.0222-69","doi-asserted-by":"crossref","unstructured":"Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, et al. (1997). Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature, 389:603-606.","DOI":"10.1038\/39321"},{"key":"key-10.14336\/AD.2020.0222-70","doi-asserted-by":"crossref","unstructured":"Krupinski J, Kumar P, Kumar S, Kaluza J (1996). Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke, 27:852-857.","DOI":"10.1161\/01.STR.27.5.852"},{"key":"key-10.14336\/AD.2020.0222-71","unstructured":"Peterson MC (2005). Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit, 11:RA229-232."},{"key":"key-10.14336\/AD.2020.0222-72","doi-asserted-by":"crossref","unstructured":"Beaufort N, Scharrer E, Kremmer E, Lux V, Ehrmann M, Huber R, et al. (2014). Cerebral small vessel disease-related protease HtrA1 processes latent TGF-beta binding protein 1 and facilitates TGF-beta signaling. Proc Natl Acad Sci U S A, 111:16496-16501.","DOI":"10.1073\/pnas.1418087111"},{"key":"key-10.14336\/AD.2020.0222-73","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN (2011). Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol, 37:94-113.","DOI":"10.1111\/j.1365-2990.2010.01147.x"},{"key":"key-10.14336\/AD.2020.0222-74","unstructured":"Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, et al. (1995). Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol, 147:53-67."},{"key":"key-10.14336\/AD.2020.0222-75","doi-asserted-by":"crossref","unstructured":"Wyss-Coray T, Borrow P, Brooker MJ, Mucke L (1997). Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol, 77:45-50.","DOI":"10.1016\/S0165-5728(97)00049-0"},{"key":"key-10.14336\/AD.2020.0222-76","doi-asserted-by":"crossref","unstructured":"Endo F, Komine O, Fujimori-Tonou N, Katsuno M, Jin S, Watanabe S, et al. (2015). Astrocyte-derived TGF-beta1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep, 11:592-604.","DOI":"10.1016\/j.celrep.2015.03.053"},{"key":"key-10.14336\/AD.2020.0222-77","doi-asserted-by":"crossref","unstructured":"Buckwalter MS, Yamane M, Coleman BS, Ormerod BK, Chin JT, Palmer T, et al. (2006). Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice. Am J Pathol, 169:154-164.","DOI":"10.2353\/ajpath.2006.051272"},{"key":"key-10.14336\/AD.2020.0222-78","doi-asserted-by":"crossref","unstructured":"Martinez-Canabal A, Wheeler AL, Sarkis D, Lerch JP, Lu WY, Buckwalter MS, et al. (2013). Chronic over-expression of TGFbeta1 alters hippocampal structure and causes learning deficits. Hippocampus, 23:1198-1211.","DOI":"10.1002\/hipo.22159"},{"key":"key-10.14336\/AD.2020.0222-79","doi-asserted-by":"crossref","unstructured":"Tong XK, Hamel E (2015). Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease. J Cereb Blood Flow Metab, 35:512-520.","DOI":"10.1038\/jcbfm.2014.226"},{"key":"key-10.14336\/AD.2020.0222-80","doi-asserted-by":"crossref","unstructured":"Gaertner RF, Wyss-Coray T, Von Euw D, Lesne S, Vivien D, Lacombe P (2005). Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiol Dis, 19:38-46.","DOI":"10.1016\/j.nbd.2004.11.008"},{"key":"key-10.14336\/AD.2020.0222-81","doi-asserted-by":"crossref","unstructured":"Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, et al. (2002). Increased levels of transforming growth factor-beta1 in essential hypertension. Am J Hypertens, 15:207-211.","DOI":"10.1016\/S0895-7061(01)02327-5"},{"key":"key-10.14336\/AD.2020.0222-82","doi-asserted-by":"crossref","unstructured":"August P, Suthanthiran M (2006). Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med, 354:2721-2723.","DOI":"10.1056\/NEJMcibr062143"},{"key":"key-10.14336\/AD.2020.0222-83","doi-asserted-by":"crossref","unstructured":"Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA (2019). Pericytes and Neurovascular Function in the Healthy and Diseased Brain. Front Cell Neurosci, 13:282.","DOI":"10.3389\/fncel.2019.00282"},{"key":"key-10.14336\/AD.2020.0222-84","doi-asserted-by":"crossref","unstructured":"Daneman R, Prat A (2015). The blood-brain barrier. Cold Spring Harb Perspect Biol, 7:a020412.","DOI":"10.1101\/cshperspect.a020412"},{"key":"key-10.14336\/AD.2020.0222-85","doi-asserted-by":"crossref","unstructured":"Iadecola C (2017). The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron, 96:17-42.","DOI":"10.1016\/j.neuron.2017.07.030"},{"key":"key-10.14336\/AD.2020.0222-86","doi-asserted-by":"crossref","unstructured":"Muoio V, Persson PB, Sendeski MM (2014). The neurovascular unit - concept review. Acta Physiol (Oxf), 210:790-798.","DOI":"10.1111\/apha.12250"},{"key":"key-10.14336\/AD.2020.0222-87","doi-asserted-by":"crossref","unstructured":"Obermeier B, Daneman R, Ransohoff RM (2013). Development, maintenance and disruption of the blood-brain barrier. Nat Med, 19:1584-1596.","DOI":"10.1038\/nm.3407"},{"key":"key-10.14336\/AD.2020.0222-88","doi-asserted-by":"crossref","unstructured":"Ballabh P, Braun A, Nedergaard M (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis, 16:1-13.","DOI":"10.1016\/j.nbd.2003.12.016"},{"key":"key-10.14336\/AD.2020.0222-89","doi-asserted-by":"crossref","unstructured":"Baeten KM, Akassoglou K (2011). Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Dev Neurobiol, 71:1018-1039.","DOI":"10.1002\/dneu.20954"},{"key":"key-10.14336\/AD.2020.0222-90","doi-asserted-by":"crossref","unstructured":"Blanchette M, Daneman R (2015). Formation and maintenance of the BBB. Mech Dev, 138 Pt 1:8-16.","DOI":"10.1016\/j.mod.2015.07.007"},{"key":"key-10.14336\/AD.2020.0222-91","doi-asserted-by":"crossref","unstructured":"Whitelock JM, Melrose J, Iozzo RV (2008). Diverse cell signaling events modulated by perlecan. Biochemistry, 47:11174-11183.","DOI":"10.1021\/bi8013938"},{"key":"key-10.14336\/AD.2020.0222-92","doi-asserted-by":"crossref","unstructured":"Shimizu F, Sano Y, Tominaga O, Maeda T, Abe MA, Kanda T (2013). Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-beta by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro. Neurobiol Aging, 34:1902-1912.","DOI":"10.1016\/j.neurobiolaging.2013.01.012"},{"key":"key-10.14336\/AD.2020.0222-93","unstructured":"Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, Ricchiuti V, et al. (2010). TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics, 7:217-229."},{"key":"key-10.14336\/AD.2020.0222-94","doi-asserted-by":"crossref","unstructured":"Winkler EA, Bell RD, Zlokovic BV (2011). Lack of Smad or Notch leads to a fatal game of brain pericyte hopscotch. Dev Cell, 20:279-280.","DOI":"10.1016\/j.devcel.2011.03.002"},{"key":"key-10.14336\/AD.2020.0222-95","doi-asserted-by":"crossref","unstructured":"Sieczkiewicz GJ, Herman IM (2003). TGF-beta 1 signaling controls retinal pericyte contractile protein expression. Microvasc Res, 66:190-196.","DOI":"10.1016\/S0026-2862(03)00055-4"},{"key":"key-10.14336\/AD.2020.0222-96","doi-asserted-by":"crossref","unstructured":"Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, et al. (2011). Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell, 20:291-302.","DOI":"10.1016\/j.devcel.2011.01.011"},{"key":"key-10.14336\/AD.2020.0222-97","doi-asserted-by":"crossref","unstructured":"Carvalho RL, Itoh F, Goumans MJ, Lebrin F, Kato M, Takahashi S, et al. (2007). Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice. J Cell Sci, 120:4269-4277.","DOI":"10.1242\/jcs.013169"},{"key":"key-10.14336\/AD.2020.0222-98","doi-asserted-by":"crossref","unstructured":"Garrido-Martin EM, Nguyen HL, Cunningham TA, Choe SW, Jiang Z, Arthur HM, et al. (2014). Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report. Arterioscler Thromb Vasc Biol, 34:2232-2236.","DOI":"10.1161\/ATVBAHA.114.303984"},{"key":"key-10.14336\/AD.2020.0222-99","doi-asserted-by":"crossref","unstructured":"Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, et al. (2010). Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res, 106:1425-1433.","DOI":"10.1161\/CIRCRESAHA.109.211037"},{"key":"key-10.14336\/AD.2020.0222-100","doi-asserted-by":"crossref","unstructured":"Mahmoud M, Upton PD, Arthur HM (2011). Angiogenesis regulation by TGFbeta signalling: clues from an inherited vascular disease. Biochem Soc Trans, 39:1659-1666.","DOI":"10.1042\/BST20110664"},{"key":"key-10.14336\/AD.2020.0222-101","doi-asserted-by":"crossref","unstructured":"Tual-Chalot S, Mahmoud M, Allinson KR, Redgrave RE, Zhai Z, Oh SP, et al. (2014). Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS One, 9:e98646.","DOI":"10.1371\/journal.pone.0098646"},{"key":"key-10.14336\/AD.2020.0222-102","doi-asserted-by":"crossref","unstructured":"Fernandez LA, Sanz-Rodriguez F, Blanco FJ, Bernabeu C, Botella LM (2006). Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res, 4:66-78.","DOI":"10.3121\/cmr.4.1.66"},{"key":"key-10.14336\/AD.2020.0222-103","doi-asserted-by":"crossref","unstructured":"Thalgott J, Dos-Santos-Luis D, Lebrin F (2015). Pericytes as targets in hereditary hemorrhagic telangiectasia. Front Genet, 6:37.","DOI":"10.3389\/fgene.2015.00037"},{"key":"key-10.14336\/AD.2020.0222-104","doi-asserted-by":"crossref","unstructured":"Gibbons GH, Dzau VJ (1994). The emerging concept of vascular remodeling. N Engl J Med, 330:1431-1438.","DOI":"10.1056\/NEJM199405193302008"},{"key":"key-10.14336\/AD.2020.0222-105","doi-asserted-by":"crossref","unstructured":"Gutierrez J, Goldman J, Dwork AJ, Elkind MS, Marshall RS, Morgello S (2015). Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology, 85:1139-1145.","DOI":"10.1212\/WNL.0000000000001976"},{"key":"key-10.14336\/AD.2020.0222-106","unstructured":"Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, et al. (1996). Vascular remodeling. Hypertension, 28:505-506."},{"key":"key-10.14336\/AD.2020.0222-107","doi-asserted-by":"crossref","unstructured":"Renna NF, de Las Heras N, Miatello RM (2013). Pathophysiology of vascular remodeling in hypertension. Int J Hypertens, 2013:808353.","DOI":"10.1155\/2013\/808353"},{"key":"key-10.14336\/AD.2020.0222-108","doi-asserted-by":"crossref","unstructured":"van Varik BJ, Rennenberg RJ, Reutelingsperger CP, Kroon AA, de Leeuw PW, Schurgers LJ (2012). Mechanisms of arterial remodeling: lessons from genetic diseases. Front Genet, 3:290.","DOI":"10.3389\/fgene.2012.00290"},{"key":"key-10.14336\/AD.2020.0222-109","doi-asserted-by":"crossref","unstructured":"Intengan HD, Schiffrin EL (2001). Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension, 38:581-587.","DOI":"10.1161\/hy09t1.096249"},{"key":"key-10.14336\/AD.2020.0222-110","doi-asserted-by":"crossref","unstructured":"Schiffrin EL (2012). Vascular remodeling in hypertension: mechanisms and treatment. Hypertension, 59:367-374.","DOI":"10.1161\/HYPERTENSIONAHA.111.187021"},{"key":"key-10.14336\/AD.2020.0222-111","doi-asserted-by":"crossref","unstructured":"Cowan DB, Langille BL (1996). Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol, 7:94-100.","DOI":"10.1097\/00041433-199604000-00008"},{"key":"key-10.14336\/AD.2020.0222-112","unstructured":"Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91:3527-3561."},{"key":"key-10.14336\/AD.2020.0222-113","doi-asserted-by":"crossref","unstructured":"Onat D, Brillon D, Colombo PC, Schmidt AM (2011). Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr Diab Rep, 11:193-202.","DOI":"10.1007\/s11892-011-0182-2"},{"key":"key-10.14336\/AD.2020.0222-114","doi-asserted-by":"crossref","unstructured":"Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, et al. (2013). The vascular endothelium and human diseases. Int J Biol Sci, 9:1057-1069.","DOI":"10.7150\/ijbs.7502"},{"key":"key-10.14336\/AD.2020.0222-115","doi-asserted-by":"crossref","unstructured":"August P, Leventhal B, Suthanthiran M (2000). Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Curr Hypertens Rep, 2:184-191.","DOI":"10.1007\/s11906-000-0080-5"},{"key":"key-10.14336\/AD.2020.0222-116","doi-asserted-by":"crossref","unstructured":"Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V (2003). Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res, 40:37-46.","DOI":"10.1159\/000068937"},{"key":"key-10.14336\/AD.2020.0222-117","doi-asserted-by":"crossref","unstructured":"Butcher JT, Nerem RM (2007). Valvular endothelial cells and the mechanoregulation of valvular pathology. Philos Trans R Soc Lond B Biol Sci, 362:1445-1457.","DOI":"10.1098\/rstb.2007.2127"},{"key":"key-10.14336\/AD.2020.0222-118","doi-asserted-by":"crossref","unstructured":"Poduri A, Chang AH, Raftrey B, Rhee S, Van M, Red-Horse K (2017). Endothelial cells respond to the direction of mechanical stimuli through SMAD signaling to regulate coronary artery size. Development, 144:3241-3252.","DOI":"10.1242\/dev.150904"},{"key":"key-10.14336\/AD.2020.0222-119","doi-asserted-by":"crossref","unstructured":"Baker AB, Ettenson DS, Jonas M, Nugent MA, Iozzo RV, Edelman ER (2008). Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res, 103:289-297.","DOI":"10.1161\/CIRCRESAHA.108.179465"},{"key":"key-10.14336\/AD.2020.0222-120","doi-asserted-by":"crossref","unstructured":"Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development, 121:1845-1854.","DOI":"10.1242\/dev.121.6.1845"},{"key":"key-10.14336\/AD.2020.0222-121","doi-asserted-by":"crossref","unstructured":"Schlecht A, Leimbeck SV, Jagle H, Feuchtinger A, Tamm ER, Braunger BM (2017). Deletion of Endothelial Transforming Growth Factor-beta Signaling Leads to Choroidal Neovascularization. Am J Pathol, 187:2570-2589.","DOI":"10.1016\/j.ajpath.2017.06.018"},{"key":"key-10.14336\/AD.2020.0222-122","doi-asserted-by":"crossref","unstructured":"Leksa V, Godar S, Schiller HB, Fuertbauer E, Muhammad A, Slezakova K, et al. (2005). TGF-beta-induced apoptosis in endothelial cells mediated by M6P\/IGFII-R and mini-plasminogen. J Cell Sci, 118:4577-4586.","DOI":"10.1242\/jcs.02587"},{"key":"key-10.14336\/AD.2020.0222-123","doi-asserted-by":"crossref","unstructured":"Pollman MJ, Naumovski L, Gibbons GH (1999). Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation, 99:2019-2026.","DOI":"10.1161\/01.CIR.99.15.2019"},{"key":"key-10.14336\/AD.2020.0222-124","doi-asserted-by":"crossref","unstructured":"Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD (1990). Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol, 111:743-755.","DOI":"10.1083\/jcb.111.2.743"},{"key":"key-10.14336\/AD.2020.0222-125","doi-asserted-by":"crossref","unstructured":"Saksela O, Moscatelli D, Rifkin DB (1987). The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol, 105:957-963.","DOI":"10.1083\/jcb.105.2.957"},{"key":"key-10.14336\/AD.2020.0222-126","doi-asserted-by":"crossref","unstructured":"Ferrari G, Terushkin V, Wolff MJ, Zhang X, Valacca C, Poggio P, et al. (2012). TGF-beta1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38beta to proapoptotic p38alpha. Mol Cancer Res, 10:605-614.","DOI":"10.1158\/1541-7786.MCR-11-0507"},{"key":"key-10.14336\/AD.2020.0222-127","doi-asserted-by":"crossref","unstructured":"Sutton AB, Canfield AE, Schor SL, Grant ME, Schor AM (1991). The response of endothelial cells to TGF beta-1 is dependent upon cell shape, proliferative state and the nature of the substratum. J Cell Sci, 99(Pt 4):777-787.","DOI":"10.1242\/jcs.99.4.777"},{"key":"key-10.14336\/AD.2020.0222-128","doi-asserted-by":"crossref","unstructured":"Thomas T, McLendon C, Sutton ET, Thomas G (1997). Cerebrovascular endothelial dysfunction mediated by beta-amyloid. Neuroreport, 8:1387-1391.","DOI":"10.1097\/00001756-199704140-00014"},{"key":"key-10.14336\/AD.2020.0222-129","doi-asserted-by":"crossref","unstructured":"Derada Troletti C, Fontijn RD, Gowing E, Charabati M, van Het Hof B, Didouh I, et al. (2019). Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology. Cell Death Dis, 10:45.","DOI":"10.1038\/s41419-018-1294-2"},{"key":"key-10.14336\/AD.2020.0222-130","doi-asserted-by":"crossref","unstructured":"Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, et al. (2019). Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol, 73:190-209.","DOI":"10.1016\/j.jacc.2018.09.089"},{"key":"key-10.14336\/AD.2020.0222-131","doi-asserted-by":"crossref","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA (2011). Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol, 179:1074-1080.","DOI":"10.1016\/j.ajpath.2011.06.001"},{"key":"key-10.14336\/AD.2020.0222-132","doi-asserted-by":"crossref","unstructured":"Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ, et al. (2015). Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am J Pathol, 185:1850-1858.","DOI":"10.1016\/j.ajpath.2015.03.019"},{"key":"key-10.14336\/AD.2020.0222-133","doi-asserted-by":"crossref","unstructured":"Krizbai IA, Gasparics A, Nagyoszi P, Fazakas C, Molnar J, Wilhelm I, et al. (2015). Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation. PLoS One, 10:e0123845.","DOI":"10.1371\/journal.pone.0123845"},{"key":"key-10.14336\/AD.2020.0222-134","doi-asserted-by":"crossref","unstructured":"Man S, Sanchez Duffhues G, Ten Dijke P, Baker D (2019). The therapeutic potential of targeting the endothelial-to-mesenchymal transition. Angiogenesis, 22:3-13.","DOI":"10.1007\/s10456-018-9639-0"},{"key":"key-10.14336\/AD.2020.0222-135","doi-asserted-by":"crossref","unstructured":"Cooley BC, Nevado J, Mellad J, Yang D, St Hilaire C, Negro A, et al. (2014). TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med, 6:227ra234.","DOI":"10.1126\/scitranslmed.3006927"},{"key":"key-10.14336\/AD.2020.0222-136","doi-asserted-by":"crossref","unstructured":"Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P (2017). TGF-beta-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci, 18.","DOI":"10.3390\/ijms18102157"},{"key":"key-10.14336\/AD.2020.0222-137","doi-asserted-by":"crossref","unstructured":"Rucker HK, Wynder HJ, Thomas WE (2000). Cellular mechanisms of CNS pericytes. Brain Res Bull, 51:363-369.","DOI":"10.1016\/S0361-9230(99)00260-9"},{"key":"key-10.14336\/AD.2020.0222-138","doi-asserted-by":"crossref","unstructured":"Sweeney MD, Ayyadurai S, Zlokovic BV (2016). Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci, 19:771-783.","DOI":"10.1038\/nn.4288"},{"key":"key-10.14336\/AD.2020.0222-139","doi-asserted-by":"crossref","unstructured":"Navarro R, Compte M, Alvarez-Vallina L, Sanz L (2016). Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity. Front Immunol, 7:480.","DOI":"10.3389\/fimmu.2016.00480"},{"key":"key-10.14336\/AD.2020.0222-140","doi-asserted-by":"crossref","unstructured":"Ando K, Fukuhara S, Izumi N, Nakajima H, Fukui H, Kelsh RN, et al. (2016). Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish. Development, 143:1328-1339.","DOI":"10.1242\/dev.132654"},{"key":"key-10.14336\/AD.2020.0222-141","doi-asserted-by":"crossref","unstructured":"Yamamoto S, Muramatsu M, Azuma E, Ikutani M, Nagai Y, Sagara H, et al. (2017). A subset of cerebrovascular pericytes originates from mature macrophages in the very early phase of vascular development in CNS. Sci Rep, 7:3855.","DOI":"10.1038\/s41598-017-03994-1"},{"key":"key-10.14336\/AD.2020.0222-142","doi-asserted-by":"crossref","unstructured":"Yamazaki T, Mukouyama YS (2018). Tissue Specific Origin, Development, and Pathological Perspectives of Pericytes. Front Cardiovasc Med, 5:78.","DOI":"10.3389\/fcvm.2018.00078"},{"key":"key-10.14336\/AD.2020.0222-143","doi-asserted-by":"crossref","unstructured":"Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, et al. (2013). Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun, 4:2932.","DOI":"10.1038\/ncomms3932"},{"key":"key-10.14336\/AD.2020.0222-144","doi-asserted-by":"crossref","unstructured":"Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV (2013). Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol, 23:303-310.","DOI":"10.1111\/bpa.12004"},{"key":"key-10.14336\/AD.2020.0222-145","doi-asserted-by":"crossref","unstructured":"Verbeek MM, de Waal RM, Schipper JJ, Van Nostrand WE (1997). Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem, 68:1135-1141.","DOI":"10.1046\/j.1471-4159.1997.68031135.x"},{"key":"key-10.14336\/AD.2020.0222-146","doi-asserted-by":"crossref","unstructured":"Cipollini V, Troili F, Giubilei F (2019). Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20112812"},{"key":"key-10.14336\/AD.2020.0222-147","doi-asserted-by":"crossref","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, et al. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med, 25:270-276.","DOI":"10.1038\/s41591-018-0297-y"},{"key":"key-10.14336\/AD.2020.0222-148","doi-asserted-by":"crossref","unstructured":"Ghosh M, Balbi M, Hellal F, Dichgans M, Lindauer U, Plesnila N (2015). Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ann Neurol, 78:887-900.","DOI":"10.1002\/ana.24512"},{"key":"key-10.14336\/AD.2020.0222-149","doi-asserted-by":"crossref","unstructured":"Geevarghese A, Herman IM (2014). Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res, 163:296-306.","DOI":"10.1016\/j.trsl.2014.01.011"},{"key":"key-10.14336\/AD.2020.0222-150","doi-asserted-by":"crossref","unstructured":"Rustenhoven J, Aalderink M, Scotter EL, Oldfield RL, Bergin PS, Mee EW, et al. (2016). TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function. J Neuroinflammation, 13:37.","DOI":"10.1186\/s12974-016-0503-0"},{"key":"key-10.14336\/AD.2020.0222-151","doi-asserted-by":"crossref","unstructured":"Hirschi KK, Rohovsky SA, D'Amore PA (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1\/2 cells and their differentiation to a smooth muscle fate. J Cell Biol, 141:805-814.","DOI":"10.1083\/jcb.141.3.805"},{"key":"key-10.14336\/AD.2020.0222-152","doi-asserted-by":"crossref","unstructured":"Jo DH, Kim JH, Heo JI, Kim JH, Cho CH (2013). Interaction between pericytes and endothelial cells leads to formation of tight junction in hyaloid vessels. Mol Cells, 36:465-471.","DOI":"10.1007\/s10059-013-0228-1"},{"key":"key-10.14336\/AD.2020.0222-153","doi-asserted-by":"crossref","unstructured":"Ramsauer M, D'Amore PA (2007). Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J Cell Sci, 120:1810-1817.","DOI":"10.1242\/jcs.003533"},{"key":"key-10.14336\/AD.2020.0222-154","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Couillard-Despres S, Raber KA, Stephan M, Lehner B, Winner B, et al. (2010). Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J Neuropathol Exp Neurol, 69:717-728.","DOI":"10.1097\/NEN.0b013e3181e4f733"},{"key":"key-10.14336\/AD.2020.0222-155","doi-asserted-by":"crossref","unstructured":"Peters S, Zitzelsperger E, Kuespert S, Iberl S, Heydn R, Johannesen S, et al. (2017). The TGF-beta System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis. Front Neurol, 8:669.","DOI":"10.3389\/fneur.2017.00669"},{"key":"key-10.14336\/AD.2020.0222-156","doi-asserted-by":"crossref","unstructured":"Castellano G, Franzin R, Stasi A, Divella C, Sallustio F, Pontrelli P, et al. (2018). Complement Activation During Ischemia\/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling. Front Immunol, 9:1002.","DOI":"10.3389\/fimmu.2018.01002"},{"key":"key-10.14336\/AD.2020.0222-157","doi-asserted-by":"crossref","unstructured":"Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. (2010). Pericytes regulate the blood-brain barrier. Nature, 468:557-561.","DOI":"10.1038\/nature09522"},{"key":"key-10.14336\/AD.2020.0222-158","doi-asserted-by":"crossref","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA (2010). Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature, 468:562-566.","DOI":"10.1038\/nature09513"},{"key":"key-10.14336\/AD.2020.0222-159","doi-asserted-by":"crossref","unstructured":"Casey CS, Atagi Y, Yamazaki Y, Shinohara M, Tachibana M, Fu Y, et al. (2015). Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway. J Biol Chem, 290:14208-14217.","DOI":"10.1074\/jbc.M114.625251"},{"key":"key-10.14336\/AD.2020.0222-160","doi-asserted-by":"crossref","unstructured":"Maas SLN, Breakefield XO, Weaver AM (2017). Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol, 27:172-188.","DOI":"10.1016\/j.tcb.2016.11.003"},{"key":"key-10.14336\/AD.2020.0222-161","doi-asserted-by":"crossref","unstructured":"Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J (2019). New windows into the brain: Central nervous system-derived extracellular vesicles in blood. Prog Neurobiol, 175:96-106.","DOI":"10.1016\/j.pneurobio.2019.01.005"},{"key":"key-10.14336\/AD.2020.0222-162","doi-asserted-by":"crossref","unstructured":"Eitan E, Hutchison ER, Marosi K, Comotto J, Mustapic M, Nigam SM, et al. (2016). Extracellular Vesicle-Associated Abeta Mediates Trans-Neuronal Bioenergetic and Ca(2+)-Handling Deficits in Alzheimer's Disease Models. NPJ Aging Mech Dis, 2.","DOI":"10.1038\/npjamd.2016.19"},{"key":"key-10.14336\/AD.2020.0222-163","doi-asserted-by":"crossref","unstructured":"Lee S, Mankhong S, Kang JH (2019). Extracellular Vesicle as a Source of Alzheimer's Biomarkers: Opportunities and Challenges. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20071728"},{"key":"key-10.14336\/AD.2020.0222-164","doi-asserted-by":"crossref","unstructured":"Saeedi S, Israel S, Nagy C, Turecki G (2019). The emerging role of exosomes in mental disorders. Transl Psychiatry, 9:122.","DOI":"10.1038\/s41398-019-0459-9"},{"key":"key-10.14336\/AD.2020.0222-165","doi-asserted-by":"crossref","unstructured":"Xiao T, Zhang W, Jiao B, Pan CZ, Liu X, Shen L (2017). The role of exosomes in the pathogenesis of Alzheimer' disease. Transl Neurodegener, 6:3.","DOI":"10.1186\/s40035-017-0072-x"},{"key":"key-10.14336\/AD.2020.0222-166","doi-asserted-by":"crossref","unstructured":"Fyfe I (2018). Exosomes can spread toxic AD pathology. Nat Rev Neurol, 14:451.","DOI":"10.1038\/s41582-018-0039-2"},{"key":"key-10.14336\/AD.2020.0222-167","doi-asserted-by":"crossref","unstructured":"Sardar Sinha M, Ansell-Schultz A, Civitelli L, Hildesjo C, Larsson M, Lannfelt L, et al. (2018). Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol, 136:41-56.","DOI":"10.1007\/s00401-018-1868-1"},{"key":"key-10.14336\/AD.2020.0222-168","doi-asserted-by":"crossref","unstructured":"Wu DM, Deng SH, Liu T, Han R, Zhang T, Xu Y (2018). TGF-beta-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression. Cancer Med, 7:5118-5129.","DOI":"10.1002\/cam4.1758"},{"key":"key-10.14336\/AD.2020.0222-169","doi-asserted-by":"crossref","unstructured":"Cherry JD, Olschowka JA, O'Banion MK (2014). Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation, 11:98.","DOI":"10.1186\/1742-2094-11-98"},{"key":"key-10.14336\/AD.2020.0222-170","doi-asserted-by":"crossref","unstructured":"Giannakis N, Sansbury BE, Patsalos A, Hays TT, Riley CO, Han X, et al. (2019). Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration. Nat Immunol, 20:626-636.","DOI":"10.1038\/s41590-019-0356-7"},{"key":"key-10.14336\/AD.2020.0222-171","doi-asserted-by":"crossref","unstructured":"Salter MW, Stevens B (2017). Microglia emerge as central players in brain disease. Nat Med, 23:1018-1027.","DOI":"10.1038\/nm.4397"},{"key":"key-10.14336\/AD.2020.0222-172","doi-asserted-by":"crossref","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017). Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci, 18:419-434.","DOI":"10.1038\/nrn.2017.48"},{"key":"key-10.14336\/AD.2020.0222-173","doi-asserted-by":"crossref","unstructured":"Giles JA, Greenhalgh AD, Davies CL, Denes A, Shaw T, Coutts G, et al. (2015). Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity. Eur J Immunol, 45:525-530.","DOI":"10.1002\/eji.201444748"},{"key":"key-10.14336\/AD.2020.0222-174","doi-asserted-by":"crossref","unstructured":"Tayebati SK, Tomassoni D, Amenta F (2016). Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study. CNS Neurol Disord Drug Targets, 15:995-1000.","DOI":"10.2174\/1871527315666160527155014"},{"key":"key-10.14336\/AD.2020.0222-175","doi-asserted-by":"crossref","unstructured":"Cipolla MJ, Liebeskind DS, Chan SL (2018). The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab, 38:2129-2149.","DOI":"10.1177\/0271678X18800589"},{"key":"key-10.14336\/AD.2020.0222-176","doi-asserted-by":"crossref","unstructured":"Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, et al. (2012). Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol, 71:743-752.","DOI":"10.1002\/ana.23529"},{"key":"key-10.14336\/AD.2020.0222-177","doi-asserted-by":"crossref","unstructured":"Wattananit S, Tornero D, Graubardt N, Memanishvili T, Monni E, Tatarishvili J, et al. (2016). Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice. J Neurosci, 36:4182-4195.","DOI":"10.1523\/JNEUROSCI.4317-15.2016"},{"key":"key-10.14336\/AD.2020.0222-178","doi-asserted-by":"crossref","unstructured":"Zoller T, Schneider A, Kleimeyer C, Masuda T, Potru PS, Pfeifer D, et al. (2018). Silencing of TGFbeta signalling in microglia results in impaired homeostasis. Nat Commun, 9:4011.","DOI":"10.1038\/s41467-018-06224-y"},{"key":"key-10.14336\/AD.2020.0222-179","doi-asserted-by":"crossref","unstructured":"Taylor RA, Chang CF, Goods BA, Hammond MD, Mac Grory B, Ai Y, et al. (2017). TGF-beta1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest, 127:280-292.","DOI":"10.1172\/JCI88647"},{"key":"key-10.14336\/AD.2020.0222-180","doi-asserted-by":"crossref","unstructured":"Li Y, Shen XZ, Li L, Zhao TV, Bernstein KE, Johnson AK, et al. (2017). Brain Transforming Growth Factor-beta Resists Hypertension Via Regulating Microglial Activation. Stroke, 48:2557-2564.","DOI":"10.1161\/STROKEAHA.117.017370"},{"key":"key-10.14336\/AD.2020.0222-181","doi-asserted-by":"crossref","unstructured":"Jo WK, Law AC, Chung SK (2014). The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol Psychiatry, 19:159-167.","DOI":"10.1038\/mp.2013.171"},{"key":"key-10.14336\/AD.2020.0222-182","doi-asserted-by":"crossref","unstructured":"Price BR, Norris CM, Sompol P, Wilcock DM (2018). An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia. J Neurochem, 144:644-650.","DOI":"10.1111\/jnc.14273"},{"key":"key-10.14336\/AD.2020.0222-183","doi-asserted-by":"crossref","unstructured":"Xu X, Zhang B, Lu K, Deng J, Zhao F, Zhao BQ, et al. (2016). Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan. Mol Neurobiol, 53:3494-3502.","DOI":"10.1007\/s12035-016-9786-5"},{"key":"key-10.14336\/AD.2020.0222-184","doi-asserted-by":"crossref","unstructured":"Nicolakakis N, Aboulkassim T, Aliaga A, Tong XK, Rosa-Neto P, Hamel E (2011). Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone. J Cereb Blood Flow Metab, 31:200-211.","DOI":"10.1038\/jcbfm.2010.78"},{"key":"key-10.14336\/AD.2020.0222-185","doi-asserted-by":"crossref","unstructured":"Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. (2012). Staging and natural history of cerebrovascular pathology in dementia. Neurology, 78:1043-1050.","DOI":"10.1212\/WNL.0b013e31824e8e7f"},{"key":"key-10.14336\/AD.2020.0222-186","doi-asserted-by":"crossref","unstructured":"Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, et al. (2008). Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke, 39:1414-1420.","DOI":"10.1161\/STROKEAHA.107.498535"},{"key":"key-10.14336\/AD.2020.0222-187","doi-asserted-by":"crossref","unstructured":"Hinman JD, Lee MD, Tung S, Vinters HV, Carmichael ST (2015). Molecular disorganization of axons adjacent to human lacunar infarcts. Brain, 138:736-745.","DOI":"10.1093\/brain\/awu398"},{"key":"key-10.14336\/AD.2020.0222-188","doi-asserted-by":"crossref","unstructured":"Skrobot OA, Attems J, Esiri M, Hortobagyi T, Ironside JW, Kalaria RN, et al. (2016). Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain, 139:2957-2969.","DOI":"10.1093\/brain\/aww214"},{"key":"key-10.14336\/AD.2020.0222-189","doi-asserted-by":"crossref","unstructured":"Rivera FJ, de la Fuente AG, Zhao C, Silva ME, Gonzalez GA, Wodnar R, et al. (2019). Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination. Glia, 67:1510-1525.","DOI":"10.1002\/glia.23624"},{"key":"key-10.14336\/AD.2020.0222-190","doi-asserted-by":"crossref","unstructured":"Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, et al. (2012). Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell, 10:96-103.","DOI":"10.1016\/j.stem.2011.11.019"},{"key":"key-10.14336\/AD.2020.0222-191","doi-asserted-by":"crossref","unstructured":"Kuriyama N, Mizuno T, Kita M, Yamada K, Ozaki E, Matsumoto S, et al. (2014). TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up. Neurol Res, 36:47-52.","DOI":"10.1179\/1743132813Y.0000000256"},{"key":"key-10.14336\/AD.2020.0222-192","doi-asserted-by":"crossref","unstructured":"Hamaguchi M, Muramatsu R, Fujimura H, Mochizuki H, Kataoka H, Yamashita T (2019). Circulating transforming growth factor-beta1 facilitates remyelination in the adult central nervous system. Elife, 8.","DOI":"10.7554\/eLife.41869"},{"key":"key-10.14336\/AD.2020.0222-193","doi-asserted-by":"crossref","unstructured":"Palazuelos J, Klingener M, Aguirre A (2014). TGFbeta signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3\/4\/FoxO1\/Sp1. J Neurosci, 34:7917-7930.","DOI":"10.1523\/JNEUROSCI.0363-14.2014"},{"key":"key-10.14336\/AD.2020.0222-194","doi-asserted-by":"crossref","unstructured":"DeKosky ST, Scheff SW (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol, 27:457-464.","DOI":"10.1002\/ana.410270502"},{"key":"key-10.14336\/AD.2020.0222-195","doi-asserted-by":"crossref","unstructured":"Henstridge CM, Tzioras M, Paolicelli RC (2019). Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration. Front Cell Neurosci, 13:63.","DOI":"10.3389\/fncel.2019.00063"},{"key":"key-10.14336\/AD.2020.0222-196","doi-asserted-by":"crossref","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol, 30:572-580.","DOI":"10.1002\/ana.410300410"},{"key":"key-10.14336\/AD.2020.0222-197","doi-asserted-by":"crossref","unstructured":"Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobagyi T, et al. (2018). Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain, 141:582-595.","DOI":"10.1093\/brain\/awx352"},{"key":"key-10.14336\/AD.2020.0222-198","doi-asserted-by":"crossref","unstructured":"Pennuto M, Bonanomi D, Benfenati F, Valtorta F (2003). Synaptophysin I controls the targeting of VAMP2\/synaptobrevin II to synaptic vesicles. Mol Biol Cell, 14:4909-4919.","DOI":"10.1091\/mbc.e03-06-0380"},{"key":"key-10.14336\/AD.2020.0222-199","doi-asserted-by":"crossref","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P (2017). Synaptic Plasticity, Dementia and Alzheimer Disease. CNS Neurol Disord Drug Targets, 16:220-233.","DOI":"10.2174\/1871527316666170113120853"},{"key":"key-10.14336\/AD.2020.0222-200","doi-asserted-by":"crossref","unstructured":"Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ (1997). Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol, 56:933-944.","DOI":"10.1097\/00005072-199708000-00011"},{"key":"key-10.14336\/AD.2020.0222-201","doi-asserted-by":"crossref","unstructured":"Chen X, Nelson CD, Li X, Winters CA, Azzam R, Sousa AA, et al. (2011). PSD-95 is required to sustain the molecular organization of the postsynaptic density. J Neurosci, 31:6329-6338.","DOI":"10.1523\/JNEUROSCI.5968-10.2011"},{"key":"key-10.14336\/AD.2020.0222-202","doi-asserted-by":"crossref","unstructured":"Lin Y, Skeberdis VA, Francesconi A, Bennett MV, Zukin RS (2004). Postsynaptic density protein-95 regulates NMDA channel gating and surface expression. J Neurosci, 24:10138-10148.","DOI":"10.1523\/JNEUROSCI.3159-04.2004"},{"key":"key-10.14336\/AD.2020.0222-203","doi-asserted-by":"crossref","unstructured":"Sinclair LI, Tayler HM, Love S (2015). Synaptic protein levels altered in vascular dementia. Neuropathol Appl Neurobiol, 41:533-543.","DOI":"10.1111\/nan.12215"},{"key":"key-10.14336\/AD.2020.0222-204","doi-asserted-by":"crossref","unstructured":"Sultana R, Banks WA, Butterfield DA (2010). Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res, 88:469-477.","DOI":"10.1002\/jnr.22227"},{"key":"key-10.14336\/AD.2020.0222-205","doi-asserted-by":"crossref","unstructured":"Antonucci F, Corradini I, Fossati G, Tomasoni R, Menna E, Matteoli M (2016). SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic Functions. Front Synaptic Neurosci, 8:7.","DOI":"10.3389\/fnsyn.2016.00007"},{"key":"key-10.14336\/AD.2020.0222-206","doi-asserted-by":"crossref","unstructured":"Bark IC, Hahn KM, Ryabinin AE, Wilson MC (1995). Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development. Proc Natl Acad Sci U S A, 92:1510-1514.","DOI":"10.1073\/pnas.92.5.1510"},{"key":"key-10.14336\/AD.2020.0222-207","doi-asserted-by":"crossref","unstructured":"Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman FC (2016). Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain? Mol Cell Proteomics, 15:409-425.","DOI":"10.1074\/mcp.R115.053330"},{"key":"key-10.14336\/AD.2020.0222-208","doi-asserted-by":"crossref","unstructured":"Takahashi H, Mizui T, Shirao T (2006). Down-regulation of drebrin A expression suppresses synaptic targeting of NMDA receptors in developing hippocampal neurones. J Neurochem, 97 Suppl 1:110-115.","DOI":"10.1111\/j.1471-4159.2005.03536.x"},{"key":"key-10.14336\/AD.2020.0222-209","doi-asserted-by":"crossref","unstructured":"Koeglsperger T, Li S, Brenneis C, Saulnier JL, Mayo L, Carrier Y, et al. (2013). Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-beta1 in the CNS. Glia, 61:985-1002.","DOI":"10.1002\/glia.22490"},{"key":"key-10.14336\/AD.2020.0222-210","doi-asserted-by":"crossref","unstructured":"Caraci F, Gulisano W, Guida CA, Impellizzeri AA, Drago F, Puzzo D, et al. (2015). A key role for TGF-beta1 in hippocampal synaptic plasticity and memory. Sci Rep, 5:11252.","DOI":"10.1038\/srep11252"},{"key":"key-10.14336\/AD.2020.0222-211","doi-asserted-by":"crossref","unstructured":"Chin J, Angers A, Cleary LJ, Eskin A, Byrne JH (2002). Transforming growth factor beta1 alters synapsin distribution and modulates synaptic depression in Aplysia. J Neurosci, 22:RC220.","DOI":"10.1523\/JNEUROSCI.22-09-j0004.2002"},{"key":"key-10.14336\/AD.2020.0222-212","doi-asserted-by":"crossref","unstructured":"Brionne TC, Tesseur I, Masliah E, Wyss-Coray T (2003). Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron, 40:1133-1145.","DOI":"10.1016\/S0896-6273(03)00766-9"},{"key":"key-10.14336\/AD.2020.0222-213","doi-asserted-by":"crossref","unstructured":"Dobolyi A, Vincze C, Pal G, Lovas G (2012). The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci, 13:8219-8258.","DOI":"10.3390\/ijms13078219"},{"key":"key-10.14336\/AD.2020.0222-214","doi-asserted-by":"crossref","unstructured":"Kashima R, Hata A (2018). The role of TGF-beta superfamily signaling in neurological disorders. Acta Biochim Biophys Sin (Shanghai), 50:106-120.","DOI":"10.1093\/abbs\/gmx124"},{"key":"key-10.14336\/AD.2020.0222-215","doi-asserted-by":"crossref","unstructured":"Vogel T, Ahrens S, Buttner N, Krieglstein K (2010). Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cereb Cortex, 20:661-671.","DOI":"10.1093\/cercor\/bhp134"},{"key":"key-10.14336\/AD.2020.0222-216","doi-asserted-by":"crossref","unstructured":"Lesne S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buee L, et al. (2003). Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem, 278:18408-18418.","DOI":"10.1074\/jbc.M300819200"},{"key":"key-10.14336\/AD.2020.0222-217","doi-asserted-by":"crossref","unstructured":"Bosco P, Ferri R, Salluzzo MG, Castellano S, Signorelli M, Nicoletti F, et al. (2013). Role of the Transforming-Growth-Factor-beta1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment. Curr Genomics, 14:147-156.","DOI":"10.2174\/1389202911314020007"},{"key":"key-10.14336\/AD.2020.0222-218","doi-asserted-by":"crossref","unstructured":"Lively S, Lam D, Wong R, Schlichter LC (2018). Comparing Effects of Transforming Growth Factor beta1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels. Front Cell Neurosci, 12:115.","DOI":"10.3389\/fncel.2018.00115"},{"key":"key-10.14336\/AD.2020.0222-219","doi-asserted-by":"crossref","unstructured":"von Bernhardi R, Cornejo F, Parada GE, Eugenin J (2015). Role of TGFbeta signaling in the pathogenesis of Alzheimer's disease. Front Cell Neurosci, 9:426.","DOI":"10.3389\/fncel.2015.00426"},{"key":"key-10.14336\/AD.2020.0222-220","doi-asserted-by":"crossref","unstructured":"Wang F, Cao Y, Ma L, Pei H, Rausch WD, Li H (2018). Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia. Front Aging Neurosci, 10:376.","DOI":"10.3389\/fnagi.2018.00376"},{"key":"key-10.14336\/AD.2020.0222-221","doi-asserted-by":"crossref","unstructured":"Marcello E, Epis R, Saraceno C, Di Luca M (2012). Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol, 970:573-601.","DOI":"10.1007\/978-3-7091-0932-8_25"},{"key":"key-10.14336\/AD.2020.0222-222","doi-asserted-by":"crossref","unstructured":"Ridler C (2018). Neurodegenerative disease: Proteome points to synaptic dysfunction in dementia. Nat Rev Neurol, 14:128.","DOI":"10.1038\/nrneurol.2018.5"},{"key":"key-10.14336\/AD.2020.0222-223","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Aigner L (2018). Neuroplasticity, limbic neuroblastosis and neuro-regenerative disorders. Neural Regen Res, 13:1322-1326.","DOI":"10.4103\/1673-5374.235214"},{"key":"key-10.14336\/AD.2020.0222-224","doi-asserted-by":"crossref","unstructured":"Qin Y, Garrison BS, Ma W, Wang R, Jiang A, Li J, et al. (2018). A Milieu Molecule for TGF-beta Required for Microglia Function in the Nervous System. Cell, 174:156-171 e116.","DOI":"10.1016\/j.cell.2018.05.027"},{"key":"key-10.14336\/AD.2020.0222-225","doi-asserted-by":"crossref","unstructured":"Wachs FP, Winner B, Couillard-Despres S, Schiller T, Aigner R, Winkler J, et al. (2006). Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J Neuropathol Exp Neurol, 65:358-370.","DOI":"10.1097\/01.jnen.0000218444.53405.f0"},{"key":"key-10.14336\/AD.2020.0222-226","doi-asserted-by":"crossref","unstructured":"Pineda JR, Daynac M, Chicheportiche A, Cebrian-Silla A, Sii Felice K, Garcia-Verdugo JM, et al. (2013). Vascular-derived TGF-beta increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain. EMBO Mol Med, 5:548-562.","DOI":"10.1002\/emmm.201202197"},{"key":"key-10.14336\/AD.2020.0222-227","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Aigner L (2018). Reactive Neuroblastosis in Huntington's Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain. Front Cell Neurosci, 12:37.","DOI":"10.3389\/fncel.2018.00037"},{"key":"key-10.14336\/AD.2020.0222-228","doi-asserted-by":"crossref","unstructured":"Gooch J, Wilcock DM (2016). Animal Models of Vascular Cognitive Impairment and Dementia (VCID). Cell Mol Neurobiol, 36:233-239.","DOI":"10.1007\/s10571-015-0286-3"},{"key":"key-10.14336\/AD.2020.0222-229","doi-asserted-by":"crossref","unstructured":"Ni J, Ohta H, Matsumoto K, Watanabe H (1994). Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res, 653:231-236.","DOI":"10.1016\/0006-8993(94)90394-8"},{"key":"key-10.14336\/AD.2020.0222-230","unstructured":"Sivilia S, Giuliani A, Del Vecchio G, Giardino L, Calza L (2008). Age-dependent impairment of hippocampal neurogenesis in chronic cerebral hypoperfusion. Neuropathol Appl Neurobiol, 34:52-61."},{"key":"key-10.14336\/AD.2020.0222-231","doi-asserted-by":"crossref","unstructured":"Choi DH, Lee KH, Lee J (2016). Effect of exercise-induced neurogenesis on cognitive function deficit in a rat model of vascular dementia. Mol Med Rep, 13:2981-2990.","DOI":"10.3892\/mmr.2016.4891"},{"key":"key-10.14336\/AD.2020.0222-232","doi-asserted-by":"crossref","unstructured":"Kwon KJ, Kim MK, Lee EJ, Kim JN, Choi BR, Kim SY, et al. (2014). Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci, 347:66-77.","DOI":"10.1016\/j.jns.2014.09.021"},{"key":"key-10.14336\/AD.2020.0222-233","doi-asserted-by":"crossref","unstructured":"Maiti P, Peruzzaro S, Kolli N, Andrews M, Al-Gharaibeh A, Rossignol J, et al. (2019). Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI. J Cell Mol Med, 23:5211-5224.","DOI":"10.1111\/jcmm.14396"},{"key":"key-10.14336\/AD.2020.0222-234","doi-asserted-by":"crossref","unstructured":"Unger MS, Schernthaner P, Marschallinger J, Mrowetz H, Aigner L (2018). Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice. J Neuroinflammation, 15:274.","DOI":"10.1186\/s12974-018-1304-4"},{"key":"key-10.14336\/AD.2020.0222-235","doi-asserted-by":"crossref","unstructured":"Winner B, Winkler J (2015). Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol, 7:a021287.","DOI":"10.1101\/cshperspect.a021287"},{"key":"key-10.14336\/AD.2020.0222-236","doi-asserted-by":"crossref","unstructured":"Raz L, Knoefel J, Bhaskar K (2016). The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab, 36:172-186.","DOI":"10.1038\/jcbfm.2015.164"},{"key":"key-10.14336\/AD.2020.0222-237","doi-asserted-by":"crossref","unstructured":"Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, et al. (2003). Transforming growth factor-beta and ischemic brain injury. Cell Mol Neurobiol, 23:539-550.","DOI":"10.1023\/A:1025072013107"},{"key":"key-10.14336\/AD.2020.0222-238","doi-asserted-by":"crossref","unstructured":"Cacheaux LP, Ivens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M, et al. (2009). Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci, 29:8927-8935.","DOI":"10.1523\/JNEUROSCI.0430-09.2009"},{"key":"key-10.14336\/AD.2020.0222-239","doi-asserted-by":"crossref","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y (2018). Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Front Immunol, 9:2122.","DOI":"10.3389\/fimmu.2018.02122"},{"key":"key-10.14336\/AD.2020.0222-240","doi-asserted-by":"crossref","unstructured":"Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, et al. (2018). Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry, 19:244-328.","DOI":"10.1080\/15622975.2017.1375556"},{"key":"key-10.14336\/AD.2020.0222-241","doi-asserted-by":"crossref","unstructured":"Galan L, Gomez-Pinedo U, Guerrero A, Garcia-Verdugo JM, Matias-Guiu J (2017). Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches. BMC Neurol, 17:173.","DOI":"10.1186\/s12883-017-0956-5"},{"key":"key-10.14336\/AD.2020.0222-242","doi-asserted-by":"crossref","unstructured":"Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, et al. (2004). Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A, 101:343-347.","DOI":"10.1073\/pnas.2634794100"},{"key":"key-10.14336\/AD.2020.0222-243","doi-asserted-by":"crossref","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013). Choosing an animal model for the study of Huntington's disease. Nat Rev Neurosci, 14:708-721.","DOI":"10.1038\/nrn3570"},{"key":"key-10.14336\/AD.2020.0222-244","doi-asserted-by":"crossref","unstructured":"Li XJ, Li S (2015). Large Animal Models of Huntington's Disease. Curr Top Behav Neurosci, 22:149-160.","DOI":"10.1007\/7854_2013_246"},{"key":"key-10.14336\/AD.2020.0222-245","doi-asserted-by":"crossref","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007). Animal models of Huntington's disease. ILAR J, 48:356-373.","DOI":"10.1093\/ilar.48.4.356"},{"key":"key-10.14336\/AD.2020.0222-246","doi-asserted-by":"crossref","unstructured":"Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ (2006). Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol, 495:70-83.","DOI":"10.1002\/cne.20840"},{"key":"key-10.14336\/AD.2020.0222-247","doi-asserted-by":"crossref","unstructured":"Wirths O (2017). Altered neurogenesis in mouse models of Alzheimer disease. Neurogenesis (Austin), 4:e1327002.","DOI":"10.1080\/23262133.2017.1327002"},{"key":"key-10.14336\/AD.2020.0222-248","doi-asserted-by":"crossref","unstructured":"Baig S, van Helmond Z, Love S (2009). Tau hyperphosphorylation affects Smad 2\/3 translocation. Neuroscience, 163:561-570.","DOI":"10.1016\/j.neuroscience.2009.06.045"},{"key":"key-10.14336\/AD.2020.0222-249","doi-asserted-by":"crossref","unstructured":"Chalmers KA, Love S (2007). Neurofibrillary tangles may interfere with Smad 2\/3 signaling in neurons. J Neuropathol Exp Neurol, 66:158-167.","DOI":"10.1097\/nen.0b013e3180303b93"},{"key":"key-10.14336\/AD.2020.0222-250","doi-asserted-by":"crossref","unstructured":"Das P, Golde T (2006). Dysfunction of TGF-beta signaling in Alzheimer's disease. J Clin Invest, 116:2855-2857.","DOI":"10.1172\/JCI30284"},{"key":"key-10.14336\/AD.2020.0222-251","doi-asserted-by":"crossref","unstructured":"Hollands C, Bartolotti N, Lazarov O (2016). Alzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared Mechanisms. Front Neurosci, 10:178.","DOI":"10.3389\/fnins.2016.00178"},{"key":"key-10.14336\/AD.2020.0222-252","doi-asserted-by":"crossref","unstructured":"Rodriguez JJ, Verkhratsky A (2011). Neurogenesis in Alzheimer's disease. J Anat, 219:78-89.","DOI":"10.1111\/j.1469-7580.2011.01343.x"},{"key":"key-10.14336\/AD.2020.0222-253","doi-asserted-by":"crossref","unstructured":"Kandasamy M, Yesudhas A, Poornimai Abirami GP, Radhakrishnan RK, Roshan SA, Johnson E, et al. (2019). Genetic reprogramming of somatic cells into neuroblasts through a co-induction of the doublecortin gene along the Yamanaka factors: A promising approach to model neuroregenerative disorders. Med Hypotheses, 127:105-111.","DOI":"10.1016\/j.mehy.2019.04.006"},{"key":"key-10.14336\/AD.2020.0222-254","doi-asserted-by":"crossref","unstructured":"Navarro V, Sanchez-Mejias E, Jimenez S, Munoz-Castro C, Sanchez-Varo R, Davila JC, et al. (2018). Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative. Front Aging Neurosci, 10:140.","DOI":"10.3389\/fnagi.2018.00140"},{"key":"key-10.14336\/AD.2020.0222-255","doi-asserted-by":"crossref","unstructured":"Gregory CD, Devitt A (2004). The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology, 113:1-14.","DOI":"10.1111\/j.1365-2567.2004.01959.x"},{"key":"key-10.14336\/AD.2020.0222-256","doi-asserted-by":"crossref","unstructured":"Lucas M, Stuart LM, Savill J, Lacy-Hulbert A (2003). Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol, 171:2610-2615.","DOI":"10.4049\/jimmunol.171.5.2610"},{"key":"key-10.14336\/AD.2020.0222-257","doi-asserted-by":"crossref","unstructured":"Velusamy T, Panneerselvam AS, Purushottam M, Anusuyadevi M, Pal PK, Jain S, et al. (2017). Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease. Oxid Med Cell Longev, 2017:3279061.","DOI":"10.1155\/2017\/3279061"},{"key":"key-10.14336\/AD.2020.0222-258","doi-asserted-by":"crossref","unstructured":"Bennett S, Grant MM, Aldred S (2009). Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis, 17:245-257.","DOI":"10.3233\/JAD-2009-1041"},{"key":"key-10.14336\/AD.2020.0222-259","doi-asserted-by":"crossref","unstructured":"Sun MS, Jin H, Sun X, Huang S, Zhang FL, Guo ZN, et al. (2018). Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy. Oxid Med Cell Longev, 2018:3804979.","DOI":"10.1155\/2018\/3804979"},{"key":"key-10.14336\/AD.2020.0222-260","doi-asserted-by":"crossref","unstructured":"Jullien P, Berg TM, Lawrence DA (1989). Acidic cellular environments: activation of latent TGF-beta and sensitization of cellular responses to TGF-beta and EGF. Int J Cancer, 43:886-891.","DOI":"10.1002\/ijc.2910430525"},{"key":"key-10.14336\/AD.2020.0222-261","doi-asserted-by":"crossref","unstructured":"Unger MS, Marschallinger J, Kaindl J, Klein B, Johnson M, Khundakar AA, et al. (2018). Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-beta plaques: A potential role in shaping plaque pathology? Alzheimers Dement, 14:1022-1037.","DOI":"10.1016\/j.jalz.2018.02.017"},{"key":"key-10.14336\/AD.2020.0222-262","doi-asserted-by":"crossref","unstructured":"Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, et al. (2008). Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med, 14:681-687.","DOI":"10.1038\/nm1781"},{"key":"key-10.14336\/AD.2020.0222-263","doi-asserted-by":"crossref","unstructured":"Bedinger D, Lao L, Khan S, Lee S, Takeuchi T, Mirza AM (2016). Development and characterization of human monoclonal antibodies that neutralize multiple TGFbeta isoforms. MAbs, 8:389-404.","DOI":"10.1080\/19420862.2015.1115166"},{"key":"key-10.14336\/AD.2020.0222-264","doi-asserted-by":"crossref","unstructured":"Taniguchi A, Matsuzaki K, Nakano K, Kan M, McKeehan WL (1998). Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit. In Vitro Cell Dev Biol Anim, 34:232-238.","DOI":"10.1007\/s11626-998-0129-3"},{"key":"key-10.14336\/AD.2020.0222-265","doi-asserted-by":"crossref","unstructured":"Nagaraj NS, Datta PK (2010). Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs, 19:77-91.","DOI":"10.1517\/13543780903382609"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-2003180701-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T02:47:59Z","timestamp":1627526879000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2020.0222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":265,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2020.0222","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}